论文部分内容阅读
AIM To evaluate the dose-limiting toxicities (DLTs)and determine the maximum-tolerated dose (MTD) andrecommended dose (RD) of combination chemotherapywith gemcitabine, cisplatin and S-1 which is an oralfluoropyrimidine pro-drug in patients with advancedbi